It’s SGX’s former Ph1 c-Met inhibitor & Derek‘s got a post on it. Lilly released that the trial was halted due to a reversible acute renal failure in the 80 mg dose group brought on by a compound crystallizing in the kidney.
Posted by kinasepro on May 6, 2009
It’s SGX’s former Ph1 c-Met inhibitor & Derek‘s got a post on it. Lilly released that the trial was halted due to a reversible acute renal failure in the 80 mg dose group brought on by a compound crystallizing in the kidney.
Posted in c-Met, SGX | 8 Comments »